Abstract
Diabetes mellitus is known as a general disturbance of glucose utilization at the cellular level. However, the precise pathomechanism is unclear, according to the 1985 classification of the WHO study Group1: Two (clinical) types of the disease—insulin-dependent diabetes mellitus (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM)—have been used. The discovery and accessibility of the hormone insulin have fundamentally changed the outcome of the patients, but complications of the disease have become conspicuous; such as increased sensitivity of the organism against different infectious illnesses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Report of WHO Study Group (1985) World Health Organization. Technical Report Series 727.
Esman V: Polymorphonuclear leukocyte in diabetes mellitus. J Clin Chem Clin Biochem 21:561– 567, 1983.
Wilson RM, Reeves WG: Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 63: 478–484, 1986.
Davidson NJ, Sowden JM, Fletscher J: Defective phagocytosis in insulin controlled diabetics: Evidence for a reaction between glucose and opsonising proteins. J Clin Pathol 37: 783–786, 1984.
Lohmann D, Krug J, Lampeter EF, Et Al: Cell-mediated immune reactions against B cells and defect of suppressor cell activity in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29:421– 425, 1986.
Dryberg T: Humoral autoimmunity in the pathogenesis of insulin dependent diabetes mellitus. Acta Endocrinol (suppl) 280: 9–29, 1986.
Komori K, Nakayama K, Aoki S, et al: Effect of anti-insulin antibody on insulin binding to liver membranes: Evidence against antibody-induced enhancement of insulin binding to the insulin receptor. Diabetologia 29: 447–452, 1986.
McEvoy RE, Witt ME, Ginsberg-Fellner F, et al: Anti-insulin antibodies in children with Type 1 diabetes mellitus. Diabetes 35: 634–641, 1986.
Blecher M: Speculations on potential anti-receptor autoimmune disease, in Pitman (ed): Receptors, antibodies and disease. Ciba foundation Symposium 90, London, 1982 pp. 279–300.
Tosi R, Vela M, Adorno D, et al: Radioimmunoassay typing gives a more precise definition of the HLA association of Type 1 (insulin-dependent) diabetes. Diabetologia 29: 430–433, 1986.
Hitman, GA: Progress with the genetics of insulin-dependent diabetes mellitus. Clin Endocrinol 25: 463–472, 1986.
Oberg G, Hallgren R, Moberg L, et al: Bactericidal protein and neutral proteases in diabetes neutrophils. Diabetologia 29: 426–429, 1986.
Keily MK, Brown JM, Thong YH: Neutrophil and monocyte adeherence in diabetes mellitus, alcoholic cirrhosis, uremia and elderly patients. Int Arch Allergy Appl Immunol 78: 132–138, 1985.
Babior BM: The respiratory burst of phagocytes. J Clin Invest 73: 599–604, 1984.
Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen radicals, transition, metals and disease. Biochem 7 219: 1–11, 1984.
Rosen H, Klebanoff S: Bactericidal activity of superoxide anion generating system. J Exp Med 149: 29–38, 1979.
Bagdade JD: Phagocytic and microbicidal function in diabetes mellitus. Acta Endrocrinol 83 (sup- pl): 27 — 33, 1976.
Nolan CM, Beaty HN, Bagdade JD: Further characterization of the impaired byctericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 27: 889–894, 1978.
Notsu K, Oka N, Note S, et al: Islet cell antibodies in the Japanese population and subjects with Type 1 (insulin-dependent) diabetes, Diabetologia 28: 660–662, 1985.
Takahashi A, Tsujihata M, Yokota A, et al: A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 378–382, 1986.
Karjalainen J, Knip M, Mustonen A, et al: Relation between insulin antibody and complement- fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 35: 620–622, 1986.
Grunfeld C, Jones DS, Shigenaga JK: Autoantibodies against the insulin receptor. Diabetes 34:205– 211, 1985.
Shoelson SE, Marshall S, Horikoshi H, et al: Antiinsulin receptor antibodies in an autoantiidiotypes. J Clin Endocrinol Metab 63: 56–61, 1986.
Proietto J, Nankervis A, Aitken P, et al: Insulin resistance in cirrhosis: Evidence for a post-receptor defect. Clin Endocrinol 21: 677–688, 1984.
Olczak SA, Greenwood RH, Hales CN: Post-receptor insulin resistance after diazoxide in non- insulin dependent diabetes. Horm Metab Res 18: 38–41, 1986.
Fovenyi J, Totpal K, Thaisz E, et al: Non-specific cellular immunity in Type I and II diabetes Exp Clin Endocrinol 83: 203–206, 1984.
Negishi K, Waldeck N, Chandy G, et al: Natural killer and islet cell activities in Type 1 (insulin- dependent) diabetes, Diabetologia 29: 352–357, 1986.
Zier KS, Leo MM, Spielman RS, et al: Decreased synthesis of Interleukin 2 (IL-2) in insulin- dependent diabetes mellitus, Diabetes 33: 552–555, 1984.
Ilonen J, Surcel HM, Mustonen A, et al: Lymphocyta subpopulations at the onset of Type 1 (insulin- dependent) diabetes. Diabetologia 27: 106–108, 1984.
Rich S, O’Neill G, Daimasso AP, et al: Complement and HLA. Diabetes 34: 504–509, 1985.
Pozzili P, Sensi M, Al-Sakkaf L, et al: Prospective study of lymphocyte subsets in subjects genetically susceptible to Type 1 (insulin-dependent) diabetes. Diabetologia 27: 132–135, 1984.
Marcelli-Barge A, Poinier JC, Schmid M, et al: Genetic polymorphism of the fourth component of complement and type 1 (Insulin-dependent) diabetes. Diabetologia 27: 116–117, 1984.
Topliss D, How J, Lewis M, Et Al: Evidence for cell-mediated immunity and specific suppressor T lymphocyta dysfunction in Graves’ disease and diabetes mellitus. J Clin Endocrinol Metab 57:700– 705, 1983.
Rodier M, Andary M, Richard JL, et al: Peripheral blood T-cell subsets studied by monoclonal antibodies in Type 1 (insulin-dependent diabetes: Effect of blood glucose control. Diabetologia 27: 136–138, 1984.
Prud’homme GJ, Colle E, Fuks A, et al: Cellular immune abnormalities and autoreactive T lymphocytes in insulin-dependent diabetes mellitus in rats. Immunol Today 6: 160–162, 1985.
Sundsmo JP, Papin RA, Wood L, et al: Complement activation in Type 1 human diabetes. Clin Immunol Immunopathol 35: 211–225, 1985.
Shah SV, Wallin JD, and Eilen SD: Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endrocrinol Metab 57: 402–409, 1983.
Matkovics B, Varga Szl, Szabo L, Et Al: The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 14: 77–79, 1982.
Markert M, Cech P, Frei J: Oxygen metabolism of phagocytosing human polymorphonuclear leukocytes in diabetes mellitus. Blut 49: 447–455, 1984.
Nath N, Chari SN, Rathi AB: Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 33: 586–589, 1984.
Theete LG, Couch RK, Buse MG, et al: The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects. Diabetologia 28: 677–682, 1985.
Thomas G, Skrinska V, Lucas FV, et al: Platelet glutathione and thromboxane synthesis in diabetes. Diabetes 34: 951–954, 1985.
Loven D, Schedl H, Wilson H, et al: Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin–induced diabetes. Diabetes 35: 503–507, 1986.
Yamamura M, Boler J, Valdimarsson H: A 5Chromium release assay for phagocytic killing of Candida albicans. J Immunol Methods 13: 227–234, 1979.
Tanabe T, Kabayashi Y, Usui T: Enhancement of human neutrophil oxygen consumption by chemotactic factors. Experientia 39: 604–611, 1983.
Cohen HJ, Chovaniek ME: Superoxide generation by digitonin-stimulated guinea pig granulocytes. J Clin Invest 40: 1081–1086, 1978.
Pick E, Keisari Y: Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages–Induction by multiple non-phagocytic stimuli. Cell Immunol 59: 301–312, 1981.
Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med 70: 150–158, 1967.
Weiss SJ, Regiani S: Neutrophils degrade subendothelial matrices in the presence of alpha-1- proteinase inhibitor: Cooperative use of lysosomal proteinases and oxygen metabolites. J Clin Invest 73: 1297–1303, 1984.
Weiss SJ, Curnutte JT, Regiani S: Neutrophil-mediated solubilization of the subendothelial matrix: Oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease of phagocytes. J Immunol 136: 636–641, 1986.
Fiilop T, Foris G, Worum I, et al: Some variations of PMNL functions with aging. Mech Aging Dev 29: 1–7, 1985.
Shah SV, Wallin JD, Cruz FC: Impaired oxidative metabolism by leukocytes from renal transplant recipients: A potential mechanism for the increased susceptibility to infections. Clin Nephrol 21:89– 92, 1984.
Kurose H, Ui M: Dual pathways of receptor-mediated cyclic GMP generation in NG 108–15 cells as differentiated by susceptibility to islet-activating protein, partussis toxin. Arch Biochem Biophys 238: 424–434, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Nagy, J.T., Fülöp, T., Paragh, G., Fóris, G. (1988). The Respiratory Burst and Diabetes Mellitus. In: Sbarra, A.J., Strauss, R.R. (eds) The Respiratory Burst and Its Physiological Significance. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5496-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5496-3_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5498-7
Online ISBN: 978-1-4684-5496-3
eBook Packages: Springer Book Archive